Can event-related potential predict the progression of mild cognitive impairment?J ClinNeurophysiol 28: 625-632

Author(s): Bennys K, Rondouin G, Benattar E, Gabelle A, Touchon J


This study was designed to evaluate the predictive value of event-related potential (ERP; N2 and P3b) in patients with mild cognitive impairment (MCI). Seventy-one patients with MCI were selected and compared with 31 healthy control subjects. They benefited from an initial assessment that included a neuropsychological evaluation and ERP. We followed them up for 1 year, and during their last visit, they benefited again from ERP and neuropsychological tests. At the end of the study, 2 subgroups of patients with MCI were differentiated according to their clinical evolution from baseline to follow-up: 41 MCI progressors (MCI-P) and 30 MCI nonprogressors (MCI-non P). The MCI-P patients had a significant decline in their executive functions compared with the MCI-non-P group at baseline and follow-up especially on trail making test B (TMT B) and verbal fluency (P < 0.0001). At baseline, MCI-P had increased P3b latencies and low P3b amplitudes compared with MCI-non P. The MCI-P showed an inversion of the P3b rostrocaudal gradient with a significant decrease in the amplitude of P3b in the parietal area compared with the MCI-non P. At follow-up, 17 MCI-P patients had converted to Alzheimer's disease (AD). There was a significant rate of decline of the amplitude of N2 and P3b in the frontal area among the groups. Furthermore, the MCI-P had a higher decrease in the rostrocaudal gradient of P3b and prolonged N2 and P3b latencies than the MCI-non P did. The sensitivity and specificity were approximately 80% and 70%, using P3b amplitude to discriminate the MCI-P from the MCI-non P. Our study underlines the interest of using N2 and P3b as neurophysiological markers for measuring MCI decline progression.

Similar Articles

Mild cognitive impairment: clinical characterization and outcome

Author(s): Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, et al.

Mild cognitive impairment: an overview

Author(s): Petersen RC, Negash S

Current concepts in mild cognitive impairment

Author(s): Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, et al.

Mild cognitive impairment: ten years later

Author(s): Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, et al.

Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain

Author(s): Alcolea D, Martínez-Lage P, Izagirre A, Clerigué M, Carmona-Iragui M, et al.

The functional neuroanatomy of target detection: an fMRI study of visual and auditory oddball tasks

Author(s): Linden DE, Prvulovic D, Formisano E, Völlinger M, Zanella FE, et al.

Usefulness of p300 in subjective memory complaints: a prospective study

Author(s): Gironell A, García-Sánchez C, Estévez-González A, Boltes A, Kulisevsky J

P300 latency and amplitude in Alzheimer's disease: a systematic review

Author(s): Pedroso RV, Fraga FJ, Corazza DI, Andreatto CA, Coelho FG, et al.

Usefulness of event-related potentials in the assessment of mild cognitive impairment

Author(s): Papaliagkas V, Kimiskidis V, Tsolaki M, Anogianakis G

Cognitive event-related potentials: longitudinal changes in mild cognitive impairment

Author(s): Papaliagkas VT, Kimiskidis VK, Tsolaki MN, Anogianakis G